Applied Molecular Transport Inc.
AMTIDelisted Dec 28, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801777
Applied Molecular Transport Inc. was delisted on Dec 28, 2023; its insiders filed their last Form 4 on Dec 29, 2023; 27 institutions reported holding it in 13F filings for Q3 2023, worth $2.44M in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 2:22 PM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Filing | 10-K | 10-K | 10-K |
| Reported | Mar 9, 2023 | Feb 24, 2022 | Mar 19, 2021 |
| Operating expenses | $127.2M | $100.8M | $66.7M |
| Research and development | $89.8M | $71.4M | $53.9M |
| Selling, general and administrative | $37.4M | $29.3M | $12.7M |
| Operating income | -$127.2M | -$100.8M | -$66.7M |
| Income tax | $0 | $0 | $0 |
| Net income | -$126.3M | -$100.3M | -$66.6M |
| EPS, basic | $-3.25 | – | – |
| EPS, diluted | $-3.25 | – | – |
| Weighted shares, basic | 38.8M | – | – |
| Weighted shares, diluted | 38.8M | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Filing | 10-K | 10-K | 10-K |
| Reported | Mar 9, 2023 | Feb 24, 2022 | Mar 19, 2021 |
| Cash and equivalents | $61.1M | $159.8M | $5.84M |
| Total current assets | $64.0M | $167.1M | $131.5M |
| Property, plant and equipment | $8.18M | $7.00M | $8.45M |
| Total assets | $107.4M | $214.0M | $140.2M |
| Accounts payable | $1.58M | $2.21M | $3.17M |
| Total current liabilities | $15.1M | $14.3M | $7.66M |
| Total liabilities | $46.6M | $50.5M | $8.51M |
| Shareholders' equity | $60.8M | $163.6M | $131.7M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Filing | 10-K | 10-K | 10-K |
| Reported | Mar 9, 2023 | Feb 24, 2022 | Mar 19, 2021 |
| Operating cash flow | -$93.9M | -$82.6M | -$58.9M |
| Capital expenditures | $4.15M | $1.86M | $5.32M |
| Free cash flow | -$98.1M | -$84.5M | -$64.2M |
| Depreciation and amortization | $3.13M | $3.25M | – |
| Stock-based compensation | $23.2M | $16.7M | $3.06M |
| Investing cash flow | -$4.15M | $122.2M | -$109.3M |
| Financing cash flow | -$733.0K | $115.3M | $161.3M |
| Net change in cash | -$98.8M | $154.9M | -$6.88M |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 2, 2023 | 41.3M | +6.1% | SEC |
| Aug 3, 2023 | 39.4M | +1.4% | SEC |
| May 4, 2023 | 39.3M | +1.8% | SEC |
| Mar 2, 2023 | 39.2M | +1.4% | SEC |
| Oct 31, 2022 | 38.9M | +1.2% | SEC |
| Jul 28, 2022 | 38.9M | +1.2% | SEC |
| May 2, 2022 | 38.7M | +1.0% | SEC |
| Mar 15, 2022 | 38.7M | +9.7% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.